key: cord-0712710-xp9u8nli authors: Arslan, Gazi; Aktürk, Hüseyin; Duman, Murat title: Clinical Characteristics of Pediatric COVID‐19 and Predictors of PCR Positivity date: 2021-01-10 journal: Pediatr Int DOI: 10.1111/ped.14602 sha: 52ba31946f04ea7fe4f30281619206176bb69dfa doc_id: 712710 cord_uid: xp9u8nli BACKGROUND: To identify the clinical findings and outcomes of children with COVID‐19 and factors predicting RT‐PCR positivity. METHODS: The data retrospectively analyzed for suspected and confirmed pediatric COVID‐19 patients between March 20 and May 31, 2020. RESULTS: There were 404 children, of them, 176 (43.6%) patients were confirmed to have COVID‐19 which were less symptomatic on admission (67.6% to 95.6%). Cough (44.9%), fever (38.1%), sore throat (18.5%), and smell‐taste loss (12.7%) were the most common symptoms. Confirmed cases had 92.6% identified history of contact with COVID‐19. Close contact with COVID‐19 positive family members and coughs increased the RT‐PCR positivity 23.8 and 5.0 times, respectively; while positivity decreased by 0.4 times if fever was over 38°C. Asymptomatic and mild cases were categorized as ‘group 1’ (n=153), moderate, severe and critical cases as ’group 2’ (n=23) in terms of disease severity. Group 2 cases had higher C‐reactive protein (40.9% to 15.9%) and procalcitonin (22.7% to 4.9%) levels and had more frequent lymphopenia (45.5% to 13.1%). Out of 23 cases, 19 had abnormal chest x‐ray findings; of them, 15 patients underwent chest CTs, and all had abnormal findings. However, 26.0% of them needed respiratory support, and no patient required invasive ventilation. CONCLUSION: Children with COVID‐19 have milder clinical course and SARS‐CoV‐2 rarely causes severe disease in children. Contact history with COVID‐19 and sore throat are the most important predictors for RT‐PCR positivity. Consequently, the role of asymptomatic children in the contamination chain must be fully established and considered for the control of pandemic. This article is protected by copyright. All rights reserved In December 8, 2019, an acute respiratory disease, soon named COVID-19, was occurred in Wuhan, China (1, 2) . As of November 22, 2020, more than 57 million cases and over 1.3 million deaths have been reported globally due to severe acute respiratory syndrome corovirus-2 (SARS-CoV-2) infection (3) . The first confirmed case in Turkey was detected on March 11, 2020 . Since then, the number of cases has increased and reached over 300 thousand. The initial data focused on the symptoms of severe respiratory failure that were being seen predominantly in adults, but information about COVID-19 in pediatric patients remained insufficient. The first infections of SARS-CoV-2 in children were reported in Shenzen on January 20 (4) . Following a small number of case series, larger data from pediatric patients in China and Italy and a systemic review including 7780 children with confirmed COVID-19 were published recently (5) (6) (7) . It is currently known that pediatric patients with COVID-19 are less likely than adults to develop severe disease (8) , but the clinical spectrum of COVID-19 in pediatric patients remains unclear. Moreover, few data are available on the management methods of COVID-19 in children (9, 10) . However, patients manifesting with severe multisystem inflammation associated with COVID-19 raise concerns about the pediatric population. Nucleic acid amplification tests (NAAT), performed with a reverse transcription polymerase chain reaction (RT-PCR) assay to detect viral RNA from the respiratory tract, are the gold standard diagnostic test for COVID-19 (11) . The accuracy and predictive values of RT-PCR tests have not been systematically evaluated. False negativity ranges from 5% to 40% , but these data are limited because there is no perfect reference standard for comparison (12, 13) . In this study, the epidemiological and clinical features, the laboratory and imaging findings, and the treatment options and clinical outcomes of suspected pediatric COVID-19 cases were identified, and the incidence and predictors of SARS-CoV-2 RT-PCR positivity were determined. Our study was designed as a single-center, retrospective, descriptive, and observational study using cross-sectional data from suspected COVID-19 patients admitted to and treated in the emergency room, inpatient clinic, or pediatric intensive care unit of a tertiary hospital in Turkey. Children between 1 month and 18 years of age were included. Suspected cases were diagnosed according to national guidelines, which have been revised intermittently according to the recommendations of the Coronavirus Scientific Advisory (14) . During the study period, our cases were defined as suspected if a child had contact with a confirmed COVID-19 case, lived in an This article is protected by copyright. All rights reserved epidemic area where COVID-19 case(s) were reported, or had any family member hospitalized due to a respiratory infection or experiencing symptoms such as cough, fever, or shortness of breath in the last 2 weeks and if the children had respiratory or gastrointestinal symptoms. Suspected cases who tested positive for nasopharyngeal swab specimens with SARS-CoV-2 RT-PCR assays were defined as confirmed cases. The diagnoses and severity of cases for all suspected patients were defined based on clinical features, laboratory testing, and imaging and included asymptomatic infection and mild, moderate, severe, and critical cases. The diagnostic criteria were as follows (5) In our study, asymptomatic and mild cases were categorized as 'group 1' and moderate, severe and critical cases as 'group 2', in terms of disease severity. All confirmed, and suspected cases were both included in the analysis. Data sets were recorded from the medical records. Information retrieved included epidemiological and clinical data, contact history, underlying disease, laboratory and imaging results, treatments used, severity of disease and outcomes. Symptoms such as sore throat and smell-taste loss cannot be described at infancy and pre-school age, sore throat was assessed for children over 3 and smell-taste loss over 5 years of age. Demographic and clinical characteristics, laboratory and imaging findings, treatments and outcomes were summarized with standard descriptive statistics for all cases. Chisquare tests and Fisher's exact tests were used for categorical variables and categorical and continuous variables were reported as frequencies and percentiles and means with standard This article is protected by copyright. All rights reserved deviations (SD) or medians with interquartile ranges (IQRs). The Mann-Whitney U test was used to compare non-parametric variables and Student's t test was performed for parametric data. Multivariate regression analysis was used to determine the risk factors for SARS-CoV-2 RT-PCR positivity and the severity of disease. All data obtained were analyzed using an IBM SPSS V22.0 program and P-values ≤ 0.05 were considered significant for all comparisons. Ethics committee approval was received from the Ethics Committee of University of Health Sciences, Derince Research and Training Hospital (Ethics Committee No: 2020-45). The study was approved by the Turkey Ministry of Health. During the study period, 404 children admitted to the emergency department and tested for months. The confirmed patients were less symptomatic on admission (67.6% to 95.6%) than the suspected cases, and the most common symptoms were cough (44.9%), fever (38.1%), sore throat (18.5%) and smell-taste loss (12.7%). Among all the patients, exposure to SARS-CoV-2 was detected in confirmed and suspected cases, at 92.6% and 23.2%, respectively. Lymphocyte counts were lower for confirmed cases, but no statistically significant difference was found between the confirmed and suspected cases in terms of lymphopenia by age (p=0.463). The confirmed cases had lower procalcitonin (6.8%) and C-reactive protein (CRP) levels (16.4%) than the suspected cases. An examination of the radiological findings showed that the confirmed cases had lower abnormalities on chest X-Rays. Chest computed tomography (CT) was performed in 19 of 176 (10.7%) confirmed cases who had pneumonia clinically, and the most common findings were bilateral ground glass opacity (36.8%), unilateral ground glass opacity (26.3%), lobar consolidation (10.5%), and diffuse infiltration (10.5%). Chest CTs were found to be normal in four patients who were clinically considered to have pneumonia. Seven patients in the suspected group had abnormal findings. Of those, only one patient had ground glass opacity on chest CT, and the other six patients had atypical abnormalities for COVID-19. Among all the patients, being asymptomatic and experiencing a mild clinical course were more common in confirmed cases (88.9% to 56.6%; p<0.001). Out of 176 confirmed cases, only one This article is protected by copyright. All rights reserved patient who had underlying primary hemophagocytic lymphohistiocytosis and immunosuppression developed mild acute respiratory distress syndrome and needed non-invasive ventilation. There was no significant difference statistically for length of stay (p=0.180) between confirmed and suspected cases, and no mortality was seen in either group. A logistic regression analysis was performed to determine the predictive factors for SARS-CoV-2 RT-PCR positivity among all patients ( Table 2) . Close contact with COVID-19 family members and coughs increased the SARS-CoV-2 RT-PCR positivity 23.8 and 5.0 times, respectively; on the other hand, positivity decreased by 0.4 times if their fever was over 38°C. Among all the patients enrolled, three were diagnosed with multisystemic hyperinflammatory syndrome in children (MIS-C) and were treated effectively with intravenous immunoglobulin, corticosteroid and supportive care. While one of them was positive for SARS-CoV-2 RT-PCR, but the other two were positive for serology. Table 3 shows the clinical, laboratory, and immunological findings and treatments of patients diagnosed with MIS-C. Regarding the severity of the disease among confirmed cases, there were 153 (86.9%) patients in group 1 (asymptomatic + mild) and 23 (13.0%) patients in group 2 (moderate + severe + critical) ( Table 4 ). The median age of the patients in group 2 was significantly higher than those in group 1 (p=0.009). A severe clinical course was most common in patients over 10 years of age (65.2%). All patients in group 2 had at least one symptom on admission, including cough, fever, or shortness of breath (p<0.001). No clinical deterioration occurred in any patient who was asymptomatic on admission. Table 5 shows the laboratory and radiological findings, diagnoses, treatments, and outcomes of COVID-19 patients in terms of severity. Lymphopenia was more common in group 2 (47.8% to 13.7%), and they had higher CRP (39.1% to 13.1%) and procalcitonin (21.7% to 4.6%) levels. Out of 23 group 2 cases, 19 (82.6%) patients had abnormal chest x-ray findings; of them, 15 patients underwent chest CTs, and all had abnormal findings. In the group 2, only 27.3% of patients needed respiratory support, and any patient required invasive ventilation. The length of hospital stays was significantly longer in the group 2 (p<0.001) and no mortality was seen in either group. Since COVID-19 was first reported in China, most of the studies published utilized information about adult patients. In the presence of this novel infection, the identification of different clinical This article is protected by copyright. All rights reserved spectrums in children is essential to guide surveillance methods and treatment strategies. The surveillance definitions and diagnostic criteria change during a pandemic, and the data from different countries vary. According to Chinese Center for Disease Control and Prevention less than 2% of the COVID-19 cases were under 10 years of age in the review of 72,314 cases (15 The sensitivity and specificity of SARS-CoV-2 RT-PCR is not well established. They are highly specific tests but have high analytic sensitivity only in ideal settings. False positive results are rare, but reported false negative rates range from 5% to 40% (21, 22) . The sensitivity of these tests likely depends on the type and quality of the specimen obtained, the duration of illness and the specific assay. Lower respiratory tract specimens and tests obtained 5 to 8 days after exposure (days 1 to 3 of illness) may be more likely to yield positive results (23) . For these reasons, we could not exclude RT-PCR negative cases and considered them as suspected cases, and we found that low degree fever, positive contact history and sore throat were factors predicting RT-PCR positivity among all patients. The clinical findings of COVID-19 are similar, but the frequency of symptoms varies in children. In addition, pediatric patients with COVID-19 appear to have a favorable clinical course; thus, their symptoms may be unrecognized before diagnosis (18, 24, 25) . Cough and fever are the most common reported symptoms in children (6) . In a review published recently including 7780 pediatric cases, 59.1% had fever, 55.9% had cough, 11.7% had shortness of breath and 19.1% were asymptomatic (7) . Although sore throat was not emphasized like common symptoms according to previous data, we found that the presence of a sore throat especially in older children who can identify it, significantly predicts the RT-PCR positivity. Nausea, diarrhea, rhinorrhea, and fatigue were also reported rarely in previous studies (7, 20) . Fever, cough, or shortness of breath This article is protected by copyright. All rights reserved were more common in adult patients (93% reported at least one of these). World Health Organization (WHO) and CDC emphasize fever and respiratory symptoms in the criteria for suspected cases. In our study only 59.1% of the confirmed cases had fever, cough or shortness of breath similar to the previous studies (19, 24, 26, 27) . Since many children are considered as asymptomatic or having mild cases, they may not be tested as often as adults, which leads to In our study, lymphopenia found in only 18.2% in the confirmed cases, while the rate was 47.8% in severe cases. Previous pediatric studies have showed that lymphopenia was reported in 12.9% of confirmed cases (27, 32). Therefore, lymphopenia may not be a reliable sign for COVID-19 but should be a significant predictor of the severity of the disease in children. During the study period, most of these confirmed cases (92.6%) were likely to have close contact with SARS-CoV-2 positive family members. This is because our government closed all schools and imposed a curfew on people under 20 and over 65 years of age in the early stages of pandemic (33). This clearly represents person-to-person transmission within family members. This transmission pattern has also been reported from studies on adult and pediatric patients (4, 5, 28, 34) . With this transmission pattern and children infected with SARS-CoV-2 presenting as mostly asymptomatic and with a milder clinical course, children's role in the contamination chain is precisely established and considered. This article is protected by copyright. All rights reserved This study has some limitations. First, we were not able to identify any other pathogens; as a result, we could not determine the exact infectious microorganism in the RT-PCR-negative group or the coinfection rates in the RT-PCR-positive group. Second, the data included only one hospital; further national and worldwide research is needed to understand COVID-19 in the pediatric population. The strength of this study is that it is the first pediatric study to determine predictive factors for RT-PCR positivity. Most of the pediatric COVID-19 cases have a favorable clinical course and SARS-CoV-2 rarely causes severe disease in children. Our findings indicate that the predictors of RT-PCR positivity in suspected cases are the presence of contact history and sore throat in terms of symptoms. Also, fever, cough, or shortness of breath, which are the most common symptoms in adults, may not be This article is protected by copyright. All rights reserved seen in pediatric patients. Therefore, the role of asymptomatic children in the contamination chain must be fully established and considered for the control of pandemic. Consequently, larger studies are needed to determine the factors predicting RT-PCR positivity and disease severity in children. Disclosure: All authors declare that they have no conflict of interest. This article is protected by copyright. All rights reserved This article is protected by copyright. All rights reserved Clinical features of patients infected with 2019 novel coronavirus in Wuhan Coronavirus Infections-More Than Just the Common Cold COVID-19 Weekly Epidemiological Update A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a Accepted Article This article is protected by copyright. All rights reserved study of a family cluster Epidemiology of COVID-19 Among Children in China SARS-CoV-2 Infection in Children COVID-19 in 7780 pediatric patients: A systematic review COVID-19 in Children: An Epidemiology Study from China Characteristics and Outcomes of Children with Coronavirus Disease Infection Admitted to US and Canadian Pediatric Intensive Care Units Updated diagnosis, treatment and prevention of COVID-19 in children: experts' consensus statement (condensed version of the second edition) Initial Public Health Response and Interim Clinical Guidance for the 2019 Novel Coronavirus Outbreak -United States COVID-19 diagnostics in context Occurrence and Timing of Subsequent Severe Acute Respiratory Syndrome Coronavirus 2 Reversetranscription Polymerase Chain Reaction Positivity Among Initially Negative Patients Halk Sağlığı Genel Müdürlüğü, COVID-19 Epidemiyoloji ve Tanı Rehberi. Haziran, 2020 COVID-19) Outbreak in China: Summary of a Report of 72314 Cases from Accepted Article This article is protected by copyright. All rights reserved the Chinese Center for Disease Control and Prevention Coronavirus Disease 2019 Case Surveillance -United States Republic of Turkey Ministry of Health. COVID-19 Weekly Situation Report Coronavirus Infection in Pediatric Emergency Departments (CONFIDENCE) Research Group. Children with Covid-19 in Pediatric Emergency Departments in Italy Epidemiology, Clinical Features, and Disease Severity in Patients With Coronavirus Disease 2019 (COVID-19) in a Children's Hospital in Characteristics and Management of Children With COVID-19 in Turkey Comparative performance of SARS-CoV-2 detection assays using seven different primerprobe sets and one assay kit Comparison of Commercially Available and Laboratory Developed Assays for in vitro Detection of SARS-CoV-2 in Clinical Laboratories Detection of SARS-CoV-2 in Different Types of Clinical Specimens Epidemiology and Clinical Features of Coronavirus disease 2019 in Children Coronavirus Infections in Children Including COVID-19 Characteristic of COVID-19 infection in pediatric patients: early findings from two Italian Accepted Article Paediatric Hospital Missed or Delayed Diagnosis of Kawasaki Disease During the 2019 Novel Coronavirus Disease (COVID-19) Pandemic Kawasaki-like disease: emerging complication during the COVID-19 pandemic Hyperinflammatory shock in children during COVID-19 pandemic An outbreak of severe Kawasaki-like disease at the Italian epicentre of the SARS-CoV-2 epidemic: an observational cohort study Accepted Article